石四药集团(02005.HK)：盐酸林可霉素注射液(2ml:0.6g)通过一致性评价

Core Viewpoint - The company Shijiazhuang Fourth Pharmaceutical Group has received approval from the National Medical Products Administration of China for its Lincomycin Hydrochloride Injection (2ml:0.6g), which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The Lincomycin Hydrochloride Injection is primarily used for patients who cannot use penicillin, treating severe infections caused by sensitive strains such as Streptococcus, Pneumococcus, and Staphylococcus [1]